Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cefazolin"" wg kryterium: Temat


Tytuł :
Rational dosage regimens for cephalothin and cefazolin using pharmacokinetics and pharmacodynamics analysis in healthy horses.
Autorzy :
Kuroda T; Clinical Veterinary Medicine Division Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Minamijima Y; Drug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Japan.
Niwa H; Microbiology Division Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Tamura N; Clinical Veterinary Medicine Division Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Mita H; Clinical Veterinary Medicine Division Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Fukuda K; Clinical Veterinary Medicine Division Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Kaimachi M; Division of Pharmacodynamics, Keio University Faculty of Pharmacy Tokyo, Japan.
Suzuki Y; Division of Pharmacodynamics, Keio University Faculty of Pharmacy Tokyo, Japan.
Enoki Y; Division of Pharmacodynamics, Keio University Faculty of Pharmacy Tokyo, Japan.
Taguchi K; Division of Pharmacodynamics, Keio University Faculty of Pharmacy Tokyo, Japan.
Matsumoto K; Division of Pharmacodynamics, Keio University Faculty of Pharmacy Tokyo, Japan.
Toutain PL; Comparative Biomedical Sciences, The Royal Veterinary College, London, UK.
Bousquet-Melou A; INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France.
Kasashima Y; Clinical Veterinary Medicine Division Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Pokaż więcej
Źródło :
Equine veterinary journal [Equine Vet J] 2021 Nov; Vol. 53 (6), pp. 1239-1249. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji :
Journal Article
MeSH Terms :
Cefazolin*/pharmacology
Cephalothin*
Animals ; Anti-Bacterial Agents/pharmacology ; Chromatography, Liquid/veterinary ; Horses ; Microbial Sensitivity Tests/veterinary ; Staphylococcus aureus ; Tandem Mass Spectrometry/veterinary
Czasopismo naukowe
Tytuł :
Effects of the cefazolin shortage on the sales, cost, and appropriate use of other antimicrobials.
Autorzy :
Koizumi R; AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Kusama Y; AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. .; Collaborative Chairs Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan. .
Asai Y; AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yoshiaki G; AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Muraki Y; Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Kyoto, Japan.
Ohmagari N; AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.; Collaborative Chairs Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan.; Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Kyoto, Japan.
Pokaż więcej
Źródło :
BMC health services research [BMC Health Serv Res] 2021 Oct 19; Vol. 21 (1), pp. 1118. Date of Electronic Publication: 2021 Oct 19.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Infective Agents*/economics
Anti-Infective Agents*/therapeutic use
Cefazolin*/supply & distribution
Drug Utilization*
Anti-Bacterial Agents/economics ; Anti-Bacterial Agents/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
Aerosol inhalation delivery of cefazolin in mice: Pharmacokinetic measurements and antibacterial effect.
Autorzy :
Valiulin SV; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia.
Onischuk AA; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia.
Baklanov AM; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia.
Dubtsov SN; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia.
An'kov SV; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia; Vorozhtsov Institute of Organic Chemistry SB RAS, Novosibirsk 630090, Russia.
Shkil NN; Siberian Federal Scientific Center of Agro-Biotechnologies RAS, Krasnoobsk 630501, Russia.
Nefedova EV; Siberian Federal Scientific Center of Agro-Biotechnologies RAS, Krasnoobsk 630501, Russia.
Plokhotnichenko ME; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia.
Tolstikova TG; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia; Vorozhtsov Institute of Organic Chemistry SB RAS, Novosibirsk 630090, Russia.
Dolgov AM; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia.
Dultseva GG; Voevodsky Institute of Chemical Kinetics and Combustion SB RAS, Novosibirsk, 630090, Russia.
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2021 Sep 25; Vol. 607, pp. 121013. Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Cefazolin*
Nebulizers and Vaporizers*
Administration, Inhalation ; Aerosols ; Animals ; Anti-Bacterial Agents ; Mice ; Particle Size
Czasopismo naukowe
Tytuł :
l-Cysteine directing synthesis of BiOBr nanosheets for efficient cefazolin photodegradation: The pivotal role of thiol.
Autorzy :
Chen Y; Engineering Research Center of Eco-environment in Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Yichang 443002, Hubei, China; College of Biology & Pharmacy, China Three Gorges University, Yichang 443002, Hubei, China.
Tian H; Engineering Research Center of Eco-environment in Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Yichang 443002, Hubei, China.
Zhu W; Engineering Research Center of Eco-environment in Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Yichang 443002, Hubei, China; College of Biology & Pharmacy, China Three Gorges University, Yichang 443002, Hubei, China.
Zhang X; Three Gorges Public Inspection and Testing Center, Yichang 443002, Hubei, China.
Li R; Engineering Research Center of Eco-environment in Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Yichang 443002, Hubei, China. Electronic address: .
Chen C; Engineering Research Center of Eco-environment in Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Yichang 443002, Hubei, China.
Huang Y; Engineering Research Center of Eco-environment in Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Yichang 443002, Hubei, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of hazardous materials [J Hazard Mater] 2021 Jul 15; Vol. 414, pp. 125544. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cefazolin*
Cysteine*
Bismuth ; Catalysis ; Ecosystem ; Photolysis ; Sulfhydryl Compounds
Czasopismo naukowe
Tytuł :
Comparison of immediate hypersensitivity reactions to preoperative antibiotics in patients labeled as penicillin allergic.
Autorzy :
Fosnot S; University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.
Currier K; University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.
Pendell J; University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.
Jeffres MN; University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO. Electronic address: .
Pokaż więcej
Źródło :
Surgery [Surgery] 2021 Sep; Vol. 170 (3), pp. 777-782. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Anti-Bacterial Agents/*adverse effects
Antibiotic Prophylaxis/*adverse effects
Cefazolin/*adverse effects
Clindamycin/*adverse effects
Drug Hypersensitivity/*etiology
Hypersensitivity, Immediate/*chemically induced
Penicillins/*adverse effects
Vancomycin/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Antibiotic Prophylaxis/methods ; Cefazolin/therapeutic use ; Clindamycin/therapeutic use ; Female ; Humans ; Intraoperative Period ; Male ; Middle Aged ; Retrospective Studies ; Surgical Procedures, Operative/adverse effects ; Surgical Procedures, Operative/methods ; Vancomycin/therapeutic use
Czasopismo naukowe
Tytuł :
Safety of administering cefazolin versus other antibiotics in penicillin-allergic patients for surgical prophylaxis at a major Canadian teaching hospital.
Autorzy :
Grant JM; ASPIRES (Antimicrobial Stewardship Programme), Medicine Quality and Safety, Vancouver Coastal Health, Vancouver, BC, Canada; Divisions of Medical Microbiology and Infection Control, and Infectious Diseases, Vancouver Coastal Health, Vancouver, BC, Canada; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada; Division of Medical Microbiology, Department of Pathology and Laboratory Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Song WHC; Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Shajari S; ASPIRES (Antimicrobial Stewardship Programme), Medicine Quality and Safety, Vancouver Coastal Health, Vancouver, BC, Canada.
Mak R; Division of Allergy and Immunology, Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Meikle AT; Department of Anesthesiology and Perioperative Care, Vancouver General Hospital and UBC Hospital, Vancouver Coastal Health, Vancouver, BC, Canada; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Partovi N; Pharmaceutical Sciences, Vancouver General Hospital, Vancouver Coastal Health, Vancouver, BC, Canada; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. Electronic address: https://twitter.com/nikepartair.
Masri BA; Department of Orthopaedics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada. Electronic address: https://twitter.com/Bas_Vancouver.
Lau TTY; ASPIRES (Antimicrobial Stewardship Programme), Medicine Quality and Safety, Vancouver Coastal Health, Vancouver, BC, Canada; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada; Pharmaceutical Sciences, Vancouver General Hospital, Vancouver Coastal Health, Vancouver, BC, Canada; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. Electronic address: .
Pokaż więcej
Źródło :
Surgery [Surgery] 2021 Sep; Vol. 170 (3), pp. 783-789. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Anti-Bacterial Agents/*adverse effects
Antibiotic Prophylaxis/*adverse effects
Cefazolin/*adverse effects
Drug Hypersensitivity/*etiology
Penicillins/*adverse effects
Anti-Bacterial Agents/therapeutic use ; Antibiotic Prophylaxis/methods ; British Columbia ; Cefazolin/therapeutic use ; Clindamycin/adverse effects ; Clindamycin/therapeutic use ; Female ; Hospitals, Teaching ; Humans ; Male ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Surgical Procedures, Operative/adverse effects ; Surgical Procedures, Operative/methods ; Surgical Wound Infection/epidemiology ; Surgical Wound Infection/prevention & control ; Vancomycin/adverse effects ; Vancomycin/therapeutic use
Czasopismo naukowe
Tytuł :
Perioperative administration of cefazolin and metronidazole in obese and non-obese patients: a pharmacokinetic study in plasma and interstitial fluid.
Autorzy :
Dorn C; Institute of Pharmacy, University of Regensburg, Regensburg, Germany.
Petroff D; Clinical Trial Centre, University of Leipzig, Leipzig, Germany.; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, Leipzig, Germany.
Stoelzel M; Department of Anaesthesiology and Intensive Care Medicine, University of Leipzig Medical Centre, Leipzig, Germany.
Kees MG; Department of Anaesthesiology, University Hospital Regensburg, Regensburg, Germany.
Kratzer A; Hospital Pharmacy, University Hospital Regensburg, Regensburg, Germany.
Dietrich A; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, Leipzig, Germany.; Department of Surgery, University of Leipzig, Leipzig, Germany.
Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.
Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Kees F; Department of Pharmacology, University of Regensburg, Regensburg, Germany.
Wrigge H; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, Leipzig, Germany.; Department of Anaesthesiology, Intensive Care and Emergency Medicine, Pain Therapy, Bergmannstrost Hospital Halle, Halle, Germany.
Simon P; Integrated Research and Treatment Center (IFB) Adiposity Diseases, University of Leipzig, Leipzig, Germany.; Department of Anaesthesiology and Intensive Care Medicine, University of Leipzig Medical Centre, Leipzig, Germany.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 15; Vol. 76 (8), pp. 2114-2120.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cefazolin*
Pharmaceutical Preparations*
Anti-Bacterial Agents ; Antibiotic Prophylaxis ; Extracellular Fluid ; Humans ; Metronidazole ; Obesity/complications
Czasopismo naukowe
Tytuł :
The Impact of Cefazolin Shortage on Surgical Site Infection Following Spine Surgery in Japan.
Autorzy :
Nakarai H; Department of Orthopaedic Surgery, Japan Organization of Occupational Health and Safety, Kanto Rosai Hospital, Kanagawa, Japan.
Yamada K; Department of Orthopaedic Surgery, Japan Organization of Occupational Health and Safety, Kanto Rosai Hospital, Kanagawa, Japan.
Tonosu J; Department of Orthopaedic Surgery, Japan Organization of Occupational Health and Safety, Kanto Rosai Hospital, Kanagawa, Japan.
Abe H; Department of Orthopaedic Surgery, Japan Organization of Occupational Health and Safety, Kanto Rosai Hospital, Kanagawa, Japan.
Watanabe K; Department of Orthopaedic Surgery, Japan Organization of Occupational Health and Safety, Kanto Rosai Hospital, Kanagawa, Japan.
Yoshida Y; Department of Orthopaedic Surgery, Japanese Red Cross Medical Center, Tokyo, Japan.
Ohya J; Department of Orthopaedic Surgery, Japanese Red Cross Medical Center, Tokyo, Japan.
Sato Y; Department of Orthopaedic Surgery, Musashino Red Cross Hospital, Tokyo, Japan.
Hara N; Department of Orthopaedic Surgery, Musashino Red Cross Hospital, Tokyo, Japan.
Okazaki R; Department of Orthopaedic Surgery, Saitama Red Cross Hospital, Saitama, Japan.
Azuma S; Department of Orthopaedic Surgery, Saitama Red Cross Hospital, Saitama, Japan.
Nakamoto H; Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Kato S; Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Oshima Y; Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Tanaka S; Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Higashikawa A; Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Spine [Spine (Phila Pa 1976)] 2021 Jul 15; Vol. 46 (14), pp. 923-930.
Typ publikacji :
Journal Article
MeSH Terms :
Surgical Wound Infection*/drug therapy
Surgical Wound Infection*/epidemiology
Anti-Bacterial Agents/*supply & distribution
Cefazolin/*supply & distribution
Spine/*surgery
Anti-Bacterial Agents/therapeutic use ; Antibiotic Prophylaxis/statistics & numerical data ; Cefazolin/therapeutic use ; Humans ; Japan ; Reoperation/statistics & numerical data ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
Autorzy :
Asada M; Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Nagata M; Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan. .; Department of Pharmacokinetics and Pharmacodynamics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. .
Mizuno T; Department of Cardiovascular Surgery, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Uchida T; Department of Anesthesiology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Takahashi H; Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Makita K; Department of Anesthesiology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Arai H; Department of Cardiovascular Surgery, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Kijima S; Office of Advanced Evaluation with Electronic Data, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan.
Echizen H; Meiji Pharmaceutical University, Tokyo, Japan.
Yasuhara M; Department of Pharmacokinetics and Pharmacodynamics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Pokaż więcej
Źródło :
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2021 May; Vol. 77 (5), pp. 735-745. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents/*pharmacokinetics
Antibiotic Prophylaxis/*methods
Cardiopulmonary Bypass/*methods
Cefazolin/*pharmacokinetics
Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/blood ; Cefazolin/administration & dosage ; Cefazolin/blood ; Computer Simulation ; Female ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Models, Biological ; Prospective Studies ; Protein Binding/physiology
Czasopismo naukowe
Tytuł :
Cefazolin as second line treatment for invasive Methicillin-Susceptible Staphylococcus aureus infection in a UK cohort of patients.
Autorzy :
Young BC; Microbiology and Infectious Diseases Department, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom; Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
Dunsmure L; Antimicrobial Pharmacy, Department of Pharmacy, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
Downs L; Microbiology and Infectious Diseases Department, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
Kildonaviciute K; Antimicrobial Pharmacy, Department of Pharmacy, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
Jones N; Microbiology and Infectious Diseases Department, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
The Journal of infection [J Infect] 2021 May; Vol. 82 (5), pp. e25-e27. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Cefazolin*/therapeutic use
Staphylococcal Infections*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Humans ; Methicillin/pharmacology ; Staphylococcus aureus ; United Kingdom/epidemiology
Raport
Tytuł :
Plasma concentrations of cefazolin in pediatric patients undergoing cardiac surgery.
Autorzy :
Lapmahapaisan S; Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Maisat W; Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Tantiwongkosri K; Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Jutasompakorn P; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Sisan W; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło :
Annals of cardiac anaesthesia [Ann Card Anaesth] 2021 Apr-Jun; Vol. 24 (2), pp. 149-154.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiac Surgical Procedures*
Cefazolin*
Anti-Bacterial Agents ; Cardiopulmonary Bypass ; Child ; Escherichia coli ; Humans ; Staphylococcus aureus
Czasopismo naukowe
Tytuł :
Reply to Kakkar et al.
Autorzy :
Honda H; Division of Infectious Diseases, Department of Infection Control, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Murakami S; Division of Infectious Diseases, Department of Infection Control, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Apr 08; Vol. 72 (7), pp. 1295-1296.
Typ publikacji :
Letter; Comment
MeSH Terms :
Cefazolin*
Humans ; Japan
Opinia redakcyjna
Tytuł :
Cefazolin Shortages in the Developing World: The Same, But Different Too.
Autorzy :
Kakkar AK; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Shafiq N; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Malhotra S; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Apr 08; Vol. 72 (7), pp. 1293-1295.
Typ publikacji :
Letter; Comment
MeSH Terms :
Cefazolin*
Humans ; Japan
Opinia redakcyjna
Tytuł :
Wound infection following implant removal of foot, ankle, lower leg or patella; a protocol for a multicenter randomized controlled trial investigating the (cost-)effectiveness of 2 g of prophylactic cefazolin compared to placebo (WIFI-2 trial).
Autorzy :
Sanders FRK; Trauma Surgery, Amsterdam UMC, Loc. AMC, G4-137, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Penning D; Trauma Surgery, Amsterdam UMC, Loc. AMC, G4-137, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Backes M; Trauma Surgery, Amsterdam UMC, Loc. AMC, G4-137, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Dingemans SA; Trauma Surgery, Amsterdam UMC, Loc. AMC, G4-137, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
van Dieren S; Trauma Surgery, Amsterdam UMC, Loc. AMC, G4-137, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Eskes AM; Trauma Surgery, Amsterdam UMC, Loc. AMC, G4-137, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Goslings JC; Trauma Surgery, OLVG, Loc. West, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands.
Kloen P; Orthopedic Surgery, Amsterdam UMC, Loc. AMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Mathôt RAA; Hospital Pharmacy, Amsterdam UMC, Loc. AMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Schep NWL; Trauma Surgery, Maasstad Ziekenhuis, Maasstadweg 21, 3079 DZ, Rotterdam, The Netherlands.
Spijkerman IJB; Medical Microbiology, Amsterdam UMC, Loc. AMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Schepers T; Trauma Surgery, Amsterdam UMC, Loc. AMC, G4-137, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło :
BMC surgery [BMC Surg] 2021 Feb 01; Vol. 21 (1), pp. 69. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Anti-Bacterial Agents*/administration & dosage
Anti-Bacterial Agents*/economics
Anti-Bacterial Agents*/therapeutic use
Cefazolin*/administration & dosage
Cefazolin*/economics
Cefazolin*/therapeutic use
Surgical Wound Infection*/drug therapy
Surgical Wound Infection*/economics
Surgical Wound Infection*/etiology
Surgical Wound Infection*/prevention & control
Bones of Lower Extremity/*surgery
Device Removal/*adverse effects
Fractures, Bone/*surgery
Adult ; Ankle ; Antibiotic Prophylaxis/economics ; Antibiotic Prophylaxis/methods ; Bones of Lower Extremity/injuries ; Cost-Benefit Analysis ; Device Removal/economics ; Double-Blind Method ; Elective Surgical Procedures/adverse effects ; Elective Surgical Procedures/economics ; Fracture Fixation, Internal/instrumentation ; Humans ; Infusions, Intravenous ; Leg ; Lower Extremity ; Patella
Czasopismo naukowe
Tytuł :
A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
Autorzy :
Rincon S; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.
Carvajal LP; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.
Gomez-Villegas SI; Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Echeverri AM; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.
Rios R; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.
Dinh A; Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Pedroza C; Center for Clinical Research and Evidence-Based Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Ordoñez KM; E.S.E. Hospital Universitario San Jorge de Pereira, Risaralda, Colombia.; Universidad Tecnológica de Pereira, Risaralda, Colombia.
Nannini E; Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Rosario, Argentina.; Instituto de Inmunología Clínica y Experimental de Rosario, CONICET, Rosario, Argentina.
Sun Z; Baylor College of Medicine, Houston, Texas, USA.
Fowler VG; Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA.
Murray BE; Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.; Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.; Department of Microbiology and Molecular Genetics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Miller WR; Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.; Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Palzkill T; Baylor College of Medicine, Houston, Texas, USA.
Diaz L; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia.
Arias CA; Center for Antimicrobial Resistance and Microbial Genomics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA .; Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.; Department of Microbiology and Molecular Genetics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.; Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Reyes J; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia .
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2021 Mar 19; Vol. 59 (4). Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cefazolin*/pharmacology
Staphylococcal Infections*/diagnosis
Staphylococcal Infections*/drug therapy
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Diagnostic Tests, Routine ; Humans ; Latin America ; Methicillin ; Microbial Sensitivity Tests ; Staphylococcus aureus/genetics
Czasopismo naukowe
Tytuł :
Population Pharmacokinetic and Pharmacodynamic Target Attainment Analysis of Cefazolin in the Serum and Hip Joint Capsule of Patients Undergoing Total Hip Arthroplasty.
Autorzy :
Komatsu T; Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan .
Natsume Y; Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan.
Uchiyama K; Department of Orthopaedic Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.
Ikeda S; Department of Orthopaedic Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.
Tomoda Y; Laboratory of Clinical Pharmacokinetics, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Tokyo, Japan.
Takayama Y; Department of Infection Control and Infectious Diseases, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Kanagawa, Japan.; Department of Infection Control and Prevention, Kitasato University Hospital, Kanagawa, Japan.
Takaso M; Department of Orthopaedic Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.
Hanaki H; Infection Control Research Center, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.
Atsuda K; Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Kanagawa, Japan.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Mar 18; Vol. 65 (4). Date of Electronic Publication: 2021 Mar 18 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Arthroplasty, Replacement, Hip*
Cefazolin*
Anti-Bacterial Agents/therapeutic use ; Humans ; Joint Capsule ; Microbial Sensitivity Tests ; Staphylococcus aureus
Czasopismo naukowe
Tytuł :
Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus.
Autorzy :
Salvador E; Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France. Electronic address: .
Oualha M; Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Bille E; Microbiological Laboratory, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France.
Beranger A; Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Moulin F; Microbiological Laboratory, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France.
Benaboud S; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Boujaafar S; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Gana I; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Urien S; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Zheng Y; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Toubiana J; Department of General Paediatrics and Paediatric Infectious Diseases, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France.
Briand C; Department of Paediatric Immunohaematology, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France.
Bustarret O; Department of Surgical Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France.
Geslain G; Department of Surgical Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France.
Renolleau S; Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France.
Treluyer JM; Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Hirt D; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Mar; Vol. 27 (3), pp. 413-419. Date of Electronic Publication: 2020 Apr 29.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Cefazolin/*pharmacokinetics
Cefazolin/*therapeutic use
Staphylococcal Infections/*drug therapy
Staphylococcal Infections/*microbiology
Staphylococcus aureus/*drug effects
Adolescent ; Anti-Bacterial Agents/blood ; Anti-Bacterial Agents/pharmacokinetics ; Cefazolin/blood ; Child ; Child, Preschool ; Critical Illness ; Dose-Response Relationship, Drug ; Female ; Humans ; Infant ; Male ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł :
Cefazolin versus ampicillin/sulbactam as an empiric antibiosis in severe odontogenic neck infection descending from the lower jaw-retrospective analysis of 350 cases.
Autorzy :
Zirk M; Department for Oral and Craniomaxillofacial and Plastic Surgery, University of Cologne, Kerpener Strasse 62, 50931, Cologne, Germany. .
Zoeller JE; Department for Oral and Craniomaxillofacial and Plastic Surgery, University of Cologne, Kerpener Strasse 62, 50931, Cologne, Germany.
Peters F; Department of Dermatology, University of Cologne, Cologne, Germany.; Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany.
Ringendahl L; Department for Oral and Craniomaxillofacial and Plastic Surgery, University of Cologne, Kerpener Strasse 62, 50931, Cologne, Germany.
Buller J; Department for Oral and Craniomaxillofacial and Plastic Surgery, University of Cologne, Kerpener Strasse 62, 50931, Cologne, Germany.
Kreppel M; Department for Oral and Craniomaxillofacial and Plastic Surgery, University of Cologne, Kerpener Strasse 62, 50931, Cologne, Germany.
Pokaż więcej
Źródło :
Clinical oral investigations [Clin Oral Investig] 2021 Feb; Vol. 25 (2), pp. 563-570. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji :
Journal Article
MeSH Terms :
Cefazolin*/therapeutic use
Sulbactam*/therapeutic use
Ampicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Antibiosis ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Quantification of microdialysis related variability in humans: Clinical trial design recommendations.
Autorzy :
Busse D; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany; Graduate Research Training Program PharMetrX, Berlin, Germany.
Simon P; Integrated Research and Treatment Center (IFB), Adiposity Diseases, University of Leipzig, Leipzig, Germany; Department of Anaesthesiology and Intensive Care Medicine, University of Leipzig Medical Centre, Leipzig, Germany.
Michelet R; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.
Ehmann L; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany; Graduate Research Training Program PharMetrX, Berlin, Germany.
Mehner F; Department of Anaesthesiology and Intensive Care Medicine, University of Leipzig Medical Centre, Leipzig, Germany.
Dorn C; Institute of Pharmacy, University of Regensburg, Regensburg, Germany.
Kratzer A; Hospital Pharmacy, University Hospital Regensburg.
Huisinga W; Institute of Mathematics, University of Potsdam, Potsdam, Germany.
Wrigge H; Integrated Research and Treatment Center (IFB), Adiposity Diseases, University of Leipzig, Leipzig, Germany; Department of Anaesthesiology, Intensive Care and Emergency Medicine, Pain Therapy, Bergmannstrost Hospital Halle, Halle, Germany.
Petroff D; Clinical Trial Centre Leipzig, University of Leipzig, Leipzig, Germany.
Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2021 Feb 01; Vol. 157, pp. 105607. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji :
Journal Article
MeSH Terms :
Cefazolin*
Calibration ; Clinical Trials as Topic ; Humans ; Microdialysis ; Prospective Studies
Czasopismo naukowe
Tytuł :
The limitations of mono- and combination antibiotic therapies on immature biofilms in a murine model of implant-associated osteomyelitis.
Autorzy :
Tomizawa T; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nishitani K; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ito H; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Advanced Medicine of Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Okae Y; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Morita Y; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Doi K; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Saito M; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ishie S; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoshida S; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Murata K; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Advanced Medicine of Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoshitomi H; Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kuroda Y; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Matsuda S; Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło :
Journal of orthopaedic research : official publication of the Orthopaedic Research Society [J Orthop Res] 2021 Feb; Vol. 39 (2), pp. 449-457. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Cefazolin/*therapeutic use
Host-Pathogen Interactions/*drug effects
Osteomyelitis/*drug therapy
Prosthesis-Related Infections/*drug therapy
Animals ; Anti-Bacterial Agents/pharmacology ; Biofilms/drug effects ; Bone and Bones/drug effects ; Bone and Bones/ultrastructure ; Cefazolin/pharmacology ; Disease Models, Animal ; Drug Therapy, Combination ; Female ; Mice, Inbred BALB C ; Osteomyelitis/microbiology ; Prosthesis-Related Infections/microbiology ; Staphylococcus aureus ; Treatment Failure
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies